CMS64v6 – Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDL-C)

Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDL-C) CMS64v4 Percentage of patients aged 20 through 79 years who had a fasting LDL-C test performed and whose risk-stratified fasting LDL-C is at or below the recommended LDL-C goal.
– INITIAL POPULATION

All patients of age 20 – 79 years before the beginning of the measurement period.

– DENOMINATOR – Patients with High Risk 

All patients aged 20 through 79 years who have one of the following:

  • Calculated LDL-C test performed during the measurement period and have CHD
  • CHD Risk Equivalent OR 10 year Framingham risk > 20%
– NUMERATOR – Patients with High Risk

Patients whose most recent fasting LDL-C test result is in good control, defined as < 100 mg/dL.

– DENOMINATOR – Patients with Moderate Risk

All patients aged 20 through 79 years who have one of the following:

  • Had a fasting LDL-C
  • A calculated LDL-C during the measurement period AND have 2 or more Major CHD Risk Factors
  • 10 year Framingham Risk 10-20%
– NUMERATOR – Patients with Moderate Risk

Patients whose most recent fasting LDL-C test result is in good control, defined as < 130 mg/dL

– DENOMINATOR – Patients with Low Risk

Patients with one of the following:

  • A fasting LDL-C test performed during the measurement period.
  • A calculated LDL-C performed up to 4 years prior to the current measurement period and have 0 or 1 Major CHD Risk Factors.
  • 10 year Framingham risk <10%
– NUMERATOR – Patients with Low Risk

Patients whose most recent fasting LDL-C test result is in good control, defined as < 160 mg/dL

– DENOMINATOR EXCLUSIONS

All patients:

    • With an active diagnosis of pregnancy.

OR

  • Who are receiving palliative care.
– APPLICATION WORKFLOW

For Denominator:
All patients 20-79 years of age before the beginning of the measurement period and have one of the following:

  • Calculated LDL-C test performed during the measurement period and have CHD (Patient > Clinical > Orders and Results > Lab)
  • CHD Risk Equivalent OR 10 year Framingham risk > 20% (Patient > Clinical > Diagnosis)

are considered as the High Risk Patients and they get included in the High Risk Patient Denominator of this measure.

Patient Denominator

All patients 20-79 years of age before the beginning of the measurement period and have one of the following:

  • Calculated LDL-C test performed during the measurement period and have CHD (Patient > Clinical > Orders and Results > Lab)
  • Current Tobacco Smoker (Patient > Clinical > History > Social)

are considered as the Moderate Risk Patients and they get included in the Moderate Risk Patient Denominator of this measure.

All patients 20-79 years of age before the beginning of the measurement period and have one of the following:

  • Calculated LDL-C test performed during the measurement period and have CHD (Patient > Clinical > Orders and Results > Lab)
  • Current Tobacco Smoker (Patient > Clinical > History > Social)
  • Laboratory Test: High Density Lipoprotein(HDL) (Patient > Clinical > Orders and Results > Lab)

are considered as the Low Risk Patients and they get included in the Low Risk Patient Denominator of this measure.

For Numerator:
In order to get included in the High Risk Numerator of the this measure, patient’s most recent fasting LDL-C test result should be is in good control, defined as < 100 mg/dL.

Patient Numerator

For Moderate Risk Numerator, patient’s most recent fasting LDL-C test result should be is in good control, defined as < 130 mg/dL and for Low Risk Numerator, fasting LDL-C test result should be < 160 mg/dL.

Denominator Exclusions:
If the patient has one of the following,

  • Receiving Palliative Care
  • An active diagnosis of pregnancy

then the patient can no longer be a part of this measure.

NOTE:
For Denominator 2 and Denominator 3, Fasting HDL-C > or equal to 60 mg/dL subtracts 1 risk from the above

NOTE:
A Low Risk Patient is included in the Numerator even if the LDL lab test are performed 4-years prior or during the measurement period.